Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
81.20
-4.40 (-5.14%)
At close: Mar 27, 2026

TPE:6919 Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
784.446,9013,422655.05594.91
Short-Term Investments
4,0762,767289.4456.18-
Cash & Short-Term Investments
4,8609,6693,7121,111594.91
Cash Growth
-49.73%160.51%234.01%86.79%535.87%
Accounts Receivable
6.495.187.893.12-
Receivables
6.495.187.893.12-
Inventory
2.882.861.022.810.05
Other Current Assets
121.5529.1223.1614.8710.32
Total Current Assets
4,9919,7063,7441,132605.27
Property, Plant & Equipment
50.7761.3280.4199.6106.38
Long-Term Investments
4,425----
Other Long-Term Assets
7.713.142.461.461.26
Total Assets
9,4749,7713,8271,233712.9
Accounts Payable
1.260.971.72.530.33
Accrued Expenses
5.051.97--30.98
Current Portion of Long-Term Debt
----1.17
Current Portion of Leases
38.888.588.227.03
Current Unearned Revenue
1.073.611.034.5-
Other Current Liabilities
35.1137.3262.3733.110.16
Total Current Liabilities
45.4952.7473.6848.3639.67
Long-Term Debt
----3.55
Long-Term Leases
-311.8720.4625.02
Pension & Post-Retirement Benefits
0.480.24---
Other Long-Term Liabilities
17.6817.71---
Total Liabilities
63.6673.785.5568.8268.24
Common Stock
776.94769.14696.62615.55535.93
Additional Paid-In Capital
8,7539,1313,271834.46217.47
Retained Earnings
80.04-56.14-227.31-286.16-107.41
Treasury Stock
-130.52--0.07-0.08-0.09
Comprehensive Income & Other
-68.54-147.470.810.49-1.24
Shareholders' Equity
9,4109,6973,7411,164644.66
Total Liabilities & Equity
9,4749,7713,8271,233712.9
Total Debt
311.8720.4628.6836.78
Net Cash (Debt)
4,8579,6573,6911,083558.13
Net Cash Growth
-49.70%161.63%240.96%93.96%-
Net Cash Per Share
3.156.752.980.920.61
Filing Date Shares Outstanding
1,5531,5381,3931,2311,072
Total Common Shares Outstanding
1,5531,5381,3931,2311,072
Working Capital
4,9469,6533,6701,084565.6
Book Value Per Share
6.066.302.690.950.60
Tangible Book Value
9,4109,6973,7411,164644.66
Tangible Book Value Per Share
6.066.302.690.950.60
Machinery
149.23138.75129.99121.55112.76
Construction In Progress
2.37-1.141.820.3
Source: S&P Global Market Intelligence. Standard template. Financial Sources.